Bioventus Acquisition Pays Off in Third Quarter

By Mike Evers

Bioventus Acquisition Pays Off in Third Quarter
The company grew nearly +27% in the third quarter of 2021, with nearly half of that growth attributable to recently acquired Bioness.

Member-Only Content

SUBSCRIBE Login

Product Labels: Synthetic Bone Graft, Viscosupplement

Tags: Revenue Report, M&A